Confrontro Tra Il Metodo Di Dosaggio Enzimatico Convenzionale E Radioimmunologico Della Fosfatasi Acida Prostatica Nel Cancro Della Prostata

1) Ackermann R. , Frohmüller H. , Wirth M. : Prostatic acid phosphatase in carcinoma of the prostate. Cost effectiveness of determination by radioimmunoassay (RIA), enzyme-linked-immunosorbent assay (ELISA) and the catalytic enzyme activity. XIX Intern. Congr. Société Intern. Urol., San Francisco 1982.

2) Bruce A. W. , Mahan D. E. , Sullivan L. D. , Goldemberg L. : The significance of prostatic acid phosphatase in adenocarcinoma of the prostate. J. Urol., 125; 357 (1981).

3) Foti A. G. , Cooper J. F. , Herschman H. , Malvaez R. R. : Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase. N. Engl. J. Med., 297; 1357 (1977).

4) Johnsson D. , Scott W. , Gibbons R. : Clinical significance of serum acid phophatase levels in advanced prostatic carcinoma. Urology, 8; 123–126 (1976).

5) Quinones G. R. , Rohner T. J. jr. , Drago J. R. , Laurance M. : Will prostatic acid phosphatase determination by radioimmunoassay increase the diagnosis of early prostatic cancer? J. Urol., 125; 361 (1981).

6) Sarosdy M. F. , Kledzik G. , Lamm L. D. : Serum and bone marrow radioimmunoassay of acid phosphatase in prostatic cancer. Urology, 19; 33–36 (1982).